Results 161 to 170 of about 69,866 (217)

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source

Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment. [PDF]

Sci Rep
Kristensen JB, Elster L, Lundh M, Ballarín-González B, Alexopoulou F, Kræmer M, Jensen DM, Leurs U, Nielsen JC, Hansen HH, Haanes KA, Degn M.   +11 more
europepmc   +1 more source

Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0

BJU International, EarlyView.
Objective To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8–20 mm in diameter on operative time, surgeon workload, and retropulsion. Subjects/Patients and Methods In our multicentre, randomised, double‐blind clinical trial, patients were randomised 1:
Kimberly A. Maciolek, Naren Nimmagadda, Aaron X. Lee, Amy M. Reed, Ryan S. Hsi, Tatsuki Koyama, Connor M. Forbes, Matthew S. Lee, Cyrus Chehroudi, Ezra J. Margolin, Ben H. Chew, Seth K. Bechis, Mitchell R. Humphreys, Michael E. Lipkin, Manoj Monga, Ojas Shah, Karen L. Stern, Roger L. Sur, Sri Sivalingam, Nicole L. Miller   +19 more
wiley   +1 more source

The quality and reliability of online video resources concerning patient education for migraine treatment in China Mainland: an electronic media-based study. [PDF]

BMC Public Health
Ge R, Xu X, Chen Y, You S, Xu J, Dai H, Huang W, Sun H, Cao Y, Chang J.   +9 more
europepmc   +1 more source

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice

British Journal of Pharmacology, EarlyView.
Background and Purpose Migraine is a neurovascular disorder largely mediated by calcitonin gene‐related peptide (CGRP). This study explores the role of the nociceptin/orphanin FQ (N/OFQ)–N/OFQ receptor (NOP) system in CGRP‐induced periorbital mechanical allodynia (PMA) in mice.
Chiara Sturaro, Pietro Pola, Michela Argentieri, Alessia Frezza, Matilde Marini, Francesco De Logu, Valentina Albanese, Marie Soukupova, Davide Malfacini, Nurulain T. Zaveri, Romina Nassini, Dane D. Jensen, Pierangelo Geppetti, Girolamo Calò, Chiara Ruzza   +14 more
wiley   +1 more source

Migraine treatment: quo vadis? Real-world data study (2015-2022) in Spain. [PDF]

BMC Neurol
Pozo-Rosich P, Carmo M, Muñiz A, Armada B, Moya-Alarcón C, Pascual J.   +5 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

New perspectives on migraine treatment: a review of the mechanisms and effects of complementary and alternative therapies. [PDF]

Front Neurol
Song X, Zhu Q, Su L, Shi L, Chi H, Yan Y, Luo M, Xu X, Liu B, Liu Z, Yang J.   +10 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route. [PDF]

Pharmaceutics
Torres J, Silva R, Farias G, Sousa Lobo JM, Ferreira DC, Silva AC.   +5 more
europepmc   +1 more source